Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 472 Jan 1 – Oct 24, 2026
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| OP Develops RNAi therapeutics for various diseases | ₩110B | StrategicUndisclosed | Biotech | South Korea | Investors | |
| ND New Dawn BioCompany profile Grows cultured wood from tree stem cells in bioreactors, eliminating the need for logging Grows cultured wood from tree stem cells in bioreactors, eliminating the need for logging | €2.1M | Pre-SeedPre-seed | Biotech, Climate tech | Netherlands | Investors | |
| AB ARTAN BioCompany profile Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions Develops mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions | $200K | Seed | Biotech | United States | Investors | |
| GT Goldenrod TherapeuticsCompany profile Develops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathways Develops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathways | $6.5M | Seed | Biotech | United States | Investors | |
| S ScispotCompany profile Provides an AI-native operating layer for life sciences labs to automate work and track samples Provides an AI-native operating layer for life sciences labs to automate work and track samples | $8M | Series A | Biotech | Canada | Investors | |
| I IngenixCompany profile Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug development Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug development | €13M | Seed+Seed | Biotech | Poland | Investors | |
| A ApohaCompany profile Apoha measures molecular behavior for pharmaceutical, food and materials research. Apoha measures molecular behavior for pharmaceutical, food and materials research. | Undisclosed | Series A | Biotech, Industrial tech | United Kingdom | Investors | |
| IH Ilant HealthCompany profile Delivers AI-enabled, value-based obesity and cardiometabolic care to employers and health plans Delivers AI-enabled, value-based obesity and cardiometabolic care to employers and health plans | $15M | Series A | Biotech, Healthtech | United States | Investors | |
| AN Advanced NanoTherapiesCompany profile Advanced NanoTherapies develops nanoparticle-coated balloons that deliver two drugs locally during vascular procedures, starting with its investigational SirPlux Duo device. Advanced NanoTherapies develops nanoparticle-coated balloons that deliver two drugs locally during vascular procedures, starting with its investigational SirPlux Duo device. | >$31M | Series B | Biotech, Healthtech | United States | Investors | |
| IB IMU BiosciencesCompany profile Profiles human immune systems using multi-omic analysis and machine learning for disease research. Profiles human immune systems using multi-omic analysis and machine learning for disease research. | $53M | Series A | Biotech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.